LLY

877.66

2.08% -19.34

시간 외 거래: 878.00 0.34 +0.04%

일라이 릴리 (LLY)

개요 뉴스 가격 이력 옵션 체인 Financials LLY 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$897.00

열려 있는:

$896

하루 거래량:

2.13M

Relative Volume:

0.71

시가총액:

$784.06B

수익:

$65.18B

순이익/손실:

$20.64B

주가수익비율:

38.85

EPS:

22.5894

순현금흐름:

$5.96B

1주 성능:

-3.12%

1개월 성능:

-16.50%

6개월 성능:

+21.23%

1년 성능:

+6.90%

1일 변동 폭

$877.11

$900.83

1주일 범위

$877.11

$926.77

52주 변동 폭

$623.78

$1,133.95

일라이 릴리 Stock (LLY) Company Profile

명칭

Lilly Eli Co

부문

Healthcare (1120)

산업

Drug Manufacturers - General (20)

전화

(317) 276-2000

주소

LILLY CORPORATE CTR, INDIANAPOLIS, IN

직원

50,000

트위터

@LillyPad

다음 수익 날짜

2024-10-30

최신 SEC 제출 서류

LLY's Discussions on Twitter

Compare LLY vs JNJ, ABBV, MRK, AZN

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
LLY Lilly Eli Co	877.66	801.34B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	240.36	576.24B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	209.32	373.42B	61.16B	4.19B	17.82B	2.3614
MRK Merck Co Inc	119.63	294.04B	64.93B	18.26B	12.36B	7.2751
AZN Astrazeneca Plc	188.48	284.42B	58.80B	10.24B	8.98B	3.2788

일라이 릴리 Stock (LLY) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-17	다운그레이드	HSBC Securities	Hold → Reduce
2026-02-25	개시	RBC Capital Mkts	Outperform
2026-02-20	개시	Barclays	Overweight
2026-01-07	재개	UBS	Buy
2025-12-16	업그레이드	Daiwa Securities	Neutral → Buy
2025-12-15	재확인	BofA Securities	Buy
2025-12-15	재확인	Goldman	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-11-10	업그레이드	Leerink Partners	Market Perform → Outperform
2025-10-20	재확인	BMO Capital Markets	Outperform
2025-10-14	업그레이드	Erste Group	Hold → Buy
2025-09-17	다운그레이드	Berenberg	Buy → Hold
2025-08-27	업그레이드	HSBC Securities	Reduce → Hold
2025-08-18	다운그레이드	Daiwa Securities	Outperform → Neutral
2025-08-07	다운그레이드	Leerink Partners	Outperform → Market Perform
2025-06-05	다운그레이드	Erste Group	Buy → Hold
2025-04-28	다운그레이드	HSBC Securities	Buy → Reduce
2025-04-22	개시	Cantor Fitzgerald	Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-10-17	개시	Bernstein	Outperform
2024-09-13	재개	Citigroup	Buy
2024-08-12	업그레이드	Deutsche Bank	Hold → Buy
2024-02-21	다운그레이드	DZ Bank	Buy → Hold
2024-02-16	재확인	Morgan Stanley	Overweight
2023-12-21	다운그레이드	Daiwa Securities	Buy → Outperform
2023-11-09	개시	Deutsche Bank	Hold
2023-10-20	재개	UBS	Buy
2023-08-09	업그레이드	Jefferies	Hold → Buy
2023-07-26	재확인	Citigroup	Buy
2023-07-14	개시	HSBC Securities	Buy
2023-05-24	재확인	BofA Securities	Buy
2023-05-24	재확인	UBS	Buy
2023-03-13	업그레이드	Wells Fargo	Equal Weight → Overweight
2023-03-06	개시	Jefferies	Hold
2023-02-15	다운그레이드	Societe Generale	Hold → Sell
2022-11-18	개시	Credit Suisse	Outperform
2022-09-22	업그레이드	UBS	Neutral → Buy
2022-05-23	개시	SVB Leerink	Outperform
2022-04-06	재개	Morgan Stanley	Overweight
2022-03-10	개시	Daiwa Securities	Outperform
2022-01-21	업그레이드	DZ Bank	Hold → Buy
2022-01-03	재확인	Bernstein	Mkt Perform
2021-12-17	개시	Goldman	Neutral
2021-12-16	재확인	BMO Capital Markets	Outperform
2021-12-16	재확인	BofA Securities	Buy
2021-12-09	재개	Wells Fargo	Equal Weight
2021-11-19	개시	BMO Capital Markets	Outperform
2021-10-11	업그레이드	Berenberg	Hold → Buy
2021-09-29	업그레이드	Citigroup	Neutral → Buy
2021-08-05	업그레이드	DZ Bank	Hold → Buy
2021-07-27	재개	Truist	Buy
2021-06-24	재확인	Cantor Fitzgerald	Overweight
2021-01-19	업그레이드	Mizuho	Neutral → Buy
2020-12-10	업그레이드	Wolfe Research	Peer Perform → Outperform
2020-11-10	재개	Bernstein	Mkt Perform
2020-09-29	개시	Berenberg	Hold
2020-09-03	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2020-06-16	업그레이드	Guggenheim	Neutral → Buy
2020-04-21	다운그레이드	UBS	Buy → Neutral
2020-04-09	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2020-02-06	개시	Mizuho	Neutral
2019-12-18	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2019-10-17	재개	BofA/Merrill	Buy
2019-05-28	개시	Goldman	Buy
2019-04-24	업그레이드	Edward Jones	Hold → Buy
2019-04-11	다운그레이드	Guggenheim	Buy → Neutral
2019-03-12	개시	JP Morgan	Overweight
2019-01-23	개시	UBS	Buy
2018-11-26	다운그레이드	Citigroup	Buy → Neutral
2018-10-31	업그레이드	Credit Suisse	Underperform → Neutral
2018-10-09	개시	Guggenheim	Buy
2018-10-01	재확인	SunTrust	Buy
2018-09-26	재개	JP Morgan	Overweight

모두보기

일라이 릴리 주식(LLY)의 최신 뉴스

04:15 AM

Eli Lilly Stock (LLY) Gets a Boost From Latest Trial Results. It Has Nothing to Do with Obesity Drugs - TipRanks

04:15 AM

01:55 AM

MDGL Stock Surges Most In A Month On Eli Lilly Buyout Speculation - Stocktwits

01:55 AM

12:24 PM

Judge Advances Lilly Suit Over Online Platforms’ Mounjaro Copies - Bloomberg Law News

12:24 PM

12:01 PM

Eli Lilly stock price forecast: bears dominate as LLY consolidates near 200-day support - Traders Union

12:01 PM

11:41 AM

Clark Foundation, Lilly to partner on new downtown basketball court - Indiana Economic Digest

11:41 AM

10:11 AM

Morgan Stanley reiterates Overweight on Eli Lilly stock, $1,313 target By Investing.com - Investing.com India

10:11 AM

09:20 AM

Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis - PR Newswire

09:00 AM

08:04 AM

AI Models Split on Eli Lilly: Strong Fundamentals, Premium Valuation - TipRanks

08:04 AM

06:21 AM

Pensionfund Sabic Buys $1.83M Stake in Eli Lilly - National Today

06:21 AM

05:52 AM

Pensionfund Sabic Makes New Investment in Eli Lilly and Company - National Today

05:52 AM

05:06 AM

Institutional Investors Are Selling One of Wall Street's Premier Trillion-Dollar Club Members (No, Not Nvidia!) - The Motley Fool

05:06 AM

03:59 AM

Bath Savings Trust Co Boosts Stake in Eli Lilly - National Today

03:59 AM

Mar 26, 2026

MDGL stock surges most in a month on Eli Lilly buyout speculation - MSN

Mar 26, 2026

Vanguard disaggregation: Eli Lilly (NYSE: LLY) ownership shows 0 shares - Stock Titan

Mar 26, 2026

Why is Eli Lilly stock down today? - Traders Union

Mar 26, 2026

The Bull Case For Eli Lilly (LLY) Could Change Following Retatrutide Milestone And Governance ShiftLearn Why - simplywall.st

Mar 26, 2026

Eli Lilly stock price forecast: consolidation after recovery as LLY holds above long-term support - Traders Union

Mar 26, 2026

Eli Lilly's Sustainability in Pharmaceuticals Strategy - Sustainability Magazine

Mar 26, 2026

Assenagon Asset Management S.A. Decreases Stock Position in Eli Lilly and Company $LLY - MarketBeat

Mar 26, 2026

Sen. Angus S. King Jr. Sells Off Shares of Eli Lilly and Company (NYSE:LLY) - MarketBeat

Mar 26, 2026

Mar 25, 2026

Eli Lilly & Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Mar 25, 2026

Buy Eli Lilly Stock (LLY) as Employers Move to Cover Obesity Drugs, Says Morgan Stanley - TipRanks

Mar 25, 2026

Is Eli Lilly (LLY) The Best Healthcare Stock to Buy According to Jim Cramer? - Insider Monkey

Mar 25, 2026

Assessing Eli Lilly (LLY) Valuation After The Recent Share Price Pullback - simplywall.st

Mar 25, 2026

Eli Lilly and the ‘societal obligation’ of GLP-1s - statnews.com

Mar 25, 2026

AI Models Split on Eli Lilly: Strong Growth vs. Premium Valuation - TipRanks

Mar 25, 2026

Spartan Planning & Wealth Management Buys Shares of 1,556 Eli Lilly and Company $LLY - MarketBeat

Mar 25, 2026

Eli Lilly and Company $LLY Shares Purchased by Dynamic Advisor Solutions LLC - MarketBeat

Mar 25, 2026

Biocon To Benefit After Eli Lilly Joins Novo Nordisk To Exit European Insulins Market - NDTV Profit

Mar 25, 2026

Mar 24, 2026

INNOVENT BIO-Eli Lilly Strategic Collaboration Deal Takes Effect; Rumored Acquisition Intent Not True - AASTOCKS.com

Mar 24, 2026

Eli Lilly to phase out select insulin products across Europe by 2027 - MSN

Mar 24, 2026

Workforce was region’s secret weapon in winning Eli Lilly | Opinion - PennLive.com

Mar 24, 2026

Martin Shkreli Says Silicon Valley's Hottest Health Obsession Is A 'Delusion' - Benzinga

Mar 24, 2026

Lilly Advances Next-Gen Diabetes Drug With Completed Pediatric PK Study - TipRanks

Mar 24, 2026

Barclays Pounds the Table on Eli Lilly Stock (LLY) as Share Price Falls - TipRanks

Mar 24, 2026

Top Analyst Reports for Eli Lilly, RTX & Abbott - Yahoo Finance

Mar 24, 2026

The Zacks Analyst Blog Highlights Eli Lilly, RTX, Abbott Laboratories, Ohio Valley Banc and Rave Restaurant - Yahoo Finance Singapore

Mar 24, 2026

Eli Lilly To Phase Out Select Insulin Products Across Europe By 2027 - Benzinga

Mar 24, 2026

Massive class action seeking RICO penalties against Takeda, Lilly presses forward with SCOTUS order - Fierce Pharma

Mar 24, 2026

Eli Lilly (NYSE:LLY) Sees Institutional Activity in Russell 1000 - Kalkine Media

Mar 24, 2026

Morgan Stanley Reiterates Overweight on Eli Lilly (LLY), Cites Growth Potential of New Platform - insidermonkey.com

Mar 24, 2026

Gradient Investments LLC Buys 19,634 Shares of Eli Lilly and Company $LLY - MarketBeat

Mar 24, 2026

Hutchens & Kramer Investment Management Group LLC Sells 3,715 Shares of Eli Lilly and Company $LLY - MarketBeat

Mar 24, 2026

Grove Bank & Trust Cuts Stock Position in Eli Lilly and Company $LLY - MarketBeat

Mar 24, 2026

Eli Lilly and Company $LLY Stock Holdings Decreased by Sarasin & Partners LLP - MarketBeat

Mar 24, 2026

Nordea Investment Management AB Raises Stock Position in Eli Lilly and Company $LLY - MarketBeat

Mar 24, 2026

Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,350 - Moomoo

Mar 24, 2026

Mar 23, 2026

Eli Lilly Stock: Analysts See 35% Upside, Driven by GLP-1 Demand and Q4 2025 ResultsNews and Statistics - IndexBox

Mar 23, 2026